Haemonetics Corporation
HAE
주식 순위
#3267
Haemonetics Corporation is a healthcare enterprise dedicated to providing... Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
주가
$118.50
마지막 동기화: 2026-10-19
시가총액
$5.39B
변동 (1일)
0.01%
변동 (1년)
133.68%
국가
US
거래 Haemonetics Corporation (HAE)
카테고리
Healthcare
Haemonetics Corporation (HAE)의 발행 주식 수
June 2026 기준 발행 주식 수: 45.36M
Haemonetics Corporation의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 45.36M입니다. March 2024 말 기준 회사는 50.71M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Haemonetics Corporation (HAE)의 발행 주식 수 기록 (2000 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 45.36M | -9.87% |
| 2025 | 50.33M | -0.74% |
| 2024 | 50.71M | -0.15% |
| 2023 | 50.78M | -0.52% |
| 2022 | 51.05M | 0.71% |
| 2021 | 50.69M | -0.01% |
| 2020 | 50.69M | -1.63% |
| 2019 | 51.53M | -2.32% |
| 2018 | 52.76M | 2.43% |
| 2017 | 51.51M | 1.17% |
| 2016 | 50.91M | -1.21% |
| 2015 | 51.53M | -0.15% |
| 2014 | 51.61M | 0.51% |
| 2013 | 51.35M | 1.22% |
| 2012 | 50.73M | 1.14% |
| 2011 | 50.15M | -1.47% |
| 2010 | 50.90M | 0.24% |
| 2009 | 50.78M | -1.68% |
| 2008 | 51.65M | -3.45% |
| 2007 | 53.49M | 1.01% |
| 2006 | 52.96M | 3.74% |
| 2005 | 51.05M | 4.45% |
| 2004 | 48.87M | -0.63% |
| 2003 | 49.18M | -6.19% |
| 2002 | 52.43M | 3.62% |
| 2001 | 50.60M | -3.02% |
| 2000 | 52.17M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 1.74B | 3,742.62% |
US
|
|
| 1.28B | 2,726.44% |
IE
|
|
| 383.50M | 745.44% |
US
|
|
| 1.48B | 3,157.42% |
US
|
|
| - | - |
DE
|
